Pyxis Oncology Profit Margin

Pyxis Oncology (PYXS) currently reports a profit margin of -803.83% as of June 2026. That compares with -1547.51% in the prior-year period — up 48.1% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Pyxis Oncology's profit margin history and peer comparisons.

Pyxis Oncology's profit margin increased from -1547.51% to -803.83% — a 48.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pyxis Oncology's profit margin of -803.83% is lower than the Healthcare sector average of 21.34%. That is roughly 3867.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Pyxis Oncology's current -803.83% should be judged against Healthcare norms (sector average: 21.34%) and against PYXS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -803.83%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Pyxis Oncology, and consider following PYXS for alerts when major investors trade the stock.